Aquablation and HoLEP are both effective tissue-removing treatments for benign prostate obstruction, but they have different strengths. HoLEP is an anatomical enucleation procedure with long-established, size-independent durability and is especially attractive for large or very large glands. Aquablation uses an ultrasound-guided robotic waterjet and has a favourable ejaculation-preservation profile, with good five-year outcomes in prostates from about 30 to 150 mL. Current evidence suggests symptom relief can be similar, while HoLEP may produce somewhat greater objective improvements in flow and residual urine. The best option often depends on gland size, ejaculation priority and the experience of the treating centre.

Quick comparison

What Aquablation means

Aquablation maps the prostate on ultrasound and ablates selected tissue with a high-pressure saline jet. The surgeon can shape the treatment to reduce damage near structures involved in ejaculation. It remains an operating-room procedure with anaesthesia, catheterisation and postoperative haemostasis.

What HoLEP means

HoLEP uses a holmium laser to separate the enlarged transition-zone adenoma from the surgical capsule, similar to shelling an orange from its peel. The tissue is moved into the bladder, morcellated and removed. Because the adenoma is enucleated rather than merely channelled, the technique works across a wide range of gland sizes.

When Aquablation may be preferred

• Preserving antegrade ejaculation is a major priority.
• Prostate size is within the centre’s Aquablation experience, including selected 80-150 mL glands.
• The patient wants strong tissue removal but wishes to avoid the high ejaculatory dysfunction rate of standard enucleation.

When HoLEP may be preferred

• The prostate is very large and maximum durable de-obstruction is the main objective.
• There is recurrent retention or a high residual where a wide anatomical enucleation is desirable.
• Histological tissue sampling is useful.
• An experienced HoLEP surgeon and morcellation setup are available and ejaculation preservation is not the leading priority.

Benefits and limitations that matter most

The most important counselling distinction is that HoLEP has a longer track record as a size-independent reference enucleation operation, whereas Aquablation’s distinctive strength is strong de-obstruction with a better chance of preserving ejaculation. Observational and network evidence suggesting better Qmax or PVR after HoLEP should not be interpreted as a major symptom difference for every patient.

Where the evidence is strongest—and where it is not

HoLEP has the longer-established evidence base as a size-independent anatomical enucleation procedure. Aquablation has strong randomised evidence versus TURP for 30-80 mL prostates and prospective five-year data in 80-150 mL glands, but long-term direct comparative evidence against enucleation remains less mature. The 2026 EAU guideline therefore supports Aquablation strongly in 30-80 mL glands while noting that durability against enucleation is still being established.

Network analyses suggesting better flow or lower residual urine after HoLEP are useful signals, but they should not be presented as if a definitive long-term head-to-head trial has already settled every outcome.

Recovery differences

Both usually involve catheterisation and short hospital observation. Burning, urgency, frequency and blood in the urine can occur after either. HoLEP has a recognised period of temporary stress leakage in some men, particularly after large-gland enucleation; Aquablation requires attention to postoperative bleeding. Heavy activity is restricted during healing for both.

What matters more than the technology name

A 100 mL prostate in a man with recurrent retention and no concern about ejaculation is a classic situation in which HoLEP has a powerful rationale. A similarly sized gland in a sexually active man who strongly values antegrade ejaculation may justify discussing Aquablation if the centre has real large-gland experience and the patient accepts that comparative durability versus enucleation is less mature. The correct choice is therefore not “robotic waterjet versus laser” in isolation; it is the clinical objective of the operation.

• Large gland plus retention, stones or need for maximal durable de-obstruction often favours HoLEP.
• Strong ejaculation priority can move Aquablation higher on the list when anatomy and local expertise are suitable.
• Need for a substantial histological tissue specimen favours HoLEP because enucleated tissue is retrieved for pathology.
• If bladder contractility is uncertain, pressure-flow urodynamics may influence expectations more than the choice between these two operations.

What to bring for consultation

• Ultrasound with prostate volume and post-void residual.
• Uroflowmetry if available.
• Urine routine/culture and serum creatinine.
• PSA report when clinically relevant.
• Medication list, especially alpha blockers, 5-alpha-reductase inhibitors and blood thinners.
• Records of catheterisation, retention or previous prostate procedures.

FAQs

Related reading

• Aquablation for Enlarged Prostate
• HoLEP Recovery: Week-by-Week Patient Guide
• Weak Bladder with Enlarged Prostate: Will Surgery Still Help?
• Which Prostate Surgery Is Best for Me? TURP, HoLEP or Other Options
• Which Prostate Treatments Can Preserve Ejaculation?
• Aquablation vs TURP: Which Is Better?
• Urine Leakage After HoLEP: Is It Temporary?
• Urologist in Latur

References

• European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male LUTS: Disease Management, 2026 https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
• American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline https://www.auanet.org/guidelines-and-quality/guidelines/bph-guideline
• National Institute for Health and Care Excellence. Transurethral water-jet ablation guidance (HTG691) https://www.nice.org.uk/guidance/htg691
• British Association of Urological Surgeons. Prostate procedures: patient information https://www.baus.org.uk/patients/information_leaflets/category/8/prostate_procedures